| __timestamp | Agios Pharmaceuticals, Inc. | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 12404000 |
| Thursday, January 1, 2015 | 141827000 | 18343000 |
| Friday, January 1, 2016 | 220163000 | 18108000 |
| Sunday, January 1, 2017 | 292681000 | 17614000 |
| Monday, January 1, 2018 | 341324000 | 35619000 |
| Tuesday, January 1, 2019 | 410894000 | 58432000 |
| Wednesday, January 1, 2020 | 367470000 | 63945000 |
| Friday, January 1, 2021 | 256973000 | 72200000 |
| Saturday, January 1, 2022 | 279910000 | 76642000 |
| Sunday, January 1, 2023 | 288903000 | 57519000 |
| Monday, January 1, 2024 | 301286000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Agios Pharmaceuticals, Inc. and Evotec SE have demonstrated contrasting strategies in their R&D investments.
Agios Pharmaceuticals has consistently outpaced Evotec SE, with its R&D expenses peaking in 2019 at nearly four times that of Evotec. This aggressive investment strategy underscores Agios's dedication to pioneering new therapies. However, post-2019, Agios's R&D spending saw a decline, dropping by approximately 30% by 2023, reflecting a possible shift in strategic focus or resource allocation.
Conversely, Evotec SE has shown a steady increase in R&D spending, with a notable 500% rise from 2014 to 2022. This gradual increase highlights Evotec's commitment to sustainable growth and innovation. As the biotech landscape evolves, these spending patterns offer insights into each company's future trajectory.
Comparing Innovation Spending: Novo Nordisk A/S and Agios Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Biogen Inc. vs Agios Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Vericel Corporation and Agios Pharmaceuticals, Inc.
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.